3/14
News Archives
A complete list of stories featured on Penn Today.
Filter Stories
Displaying 10171 - 10180 of 18688
Archive ・ Penn Current
Penn in Washington absorbs D.C. semester program
After two decades as a summer internship program, Penn in Washington (PIW) has expanded to include the Washington Semester Program formerly run by the Department of Political Science in the School of Arts & Sciences. The Semester Program enables students interested in public policy to live, learn, and work in the nation’s capital during the school year.
Archive ・ Penn Current
Tune in to Penn Vet’s ‘foal cam’ to view live birth
With this season of “Downton Abbey” concluded and “House of Cards” likely consumed in a binge-viewing session, fans of drama might be feeling at a loss. Fortunately, the School of Veterinary Medicine has a means to fill the void. A live webcast from the New Bolton Center Campus is shining a spotlight on one of life’s most dramatic events: birth.
Archive ・ Penn News
A Tale of Two Cities: Penn Student Capitalizes on Semester in Washington
This spring, while his peers at the University of Pennsylvania are back on campus in Philadelphia, sophomore Ben Stollman is spending the semester in Washington, D.C. Stollman is participating in the Penn in Washington Semester program, which provides select students interested in public policy with the chance to live, learn and work in the hub of national political action.
Archive ・ Penn News
Penn Medicine Researchers Ask: Can A Story Help Doctors Curb the Prescription Opioid Abuse Epidemic?
In the fight against a nationwide prescription opioid abuse epidemic, Penn Medicine researchers are using storytelling to help doctors recall important, potentially lifesaving national guidelines on how to prescribe these medications.
Archive ・ Penn News
Penn Study Shows Way to Make Treatment of Rare Blood Disorder More Affordable and Effective
A University of Pennsylvania research team has defined a possible new way to fight a disease that is currently treatable only with the most expensive drug available for sale in the United States. In a study published this month in Blood, the Penn team describes the strategy, based on the oldest part of the human immune system – called “complement” -- that could turn out to be less costly and more effective for the majority of patients with a rare blood disorder.
Archive ・ Penn News
Annenberg Student Work To Be Highlighted at 2014 Screening Scholarship Media Festival
The documentary, “The 3,100-mile Self-transcendence Race” by doctoral students Corrina Laughlin and Kevin Gotkin, and a series of radio documentaries produced by Annenberg undergraduate students in
Archive ・ Penn News
Fels Institute of Government Hosts Final Round of Penn Public Policy Challenge
On March 2, five teams of University of Pennsylvania students with new public policy ideas for Philadelphia will compete in the final round of competition in the Fels Institute of Government’s annual Penn Public Policy Challenge.
Archive ・ Penn News
Penn Researchers Show Nuclear Stiffness Keeps Stem Cells and Cancer Cells in Place
Adult stem cells and cancer cells have many things in common, including an ability to migrate through tiny gaps in tissue. Both types of cells also experience a trade-off when it comes to this ability; having a flexible nucleus makes migration easier but is worse at protecting the nucleus’ DNA compared to a stiffer nucleus. Nuclear proteins that regulate nuclear stiffness are therefore thought to control processes as diverse as tissue repair and tumor growth.
Archive ・ Penn News
After a Decade, Penn Institute of Urban Research Celebrates Partnerships and Progress
With the number of city dwellers expected to double in the next 30 years, bringing the tally to 7 billion city inhabitants worldwide, urbanization poses a wide range of critical issues, including housing, education, food security, energy, crime, economic development, income equality and public health.
Archive ・ Penn News
Penn Study: Blocking Autophagy with Malaria Drug May Help Overcome Resistance to BRAF Drugs in Melanoma
Half of melanoma patients with the BRAF mutation have a positive response to treatment with BRAF inhibitors, but nearly all of those patients develop resistance to the drugs and experience disease progression.